title: Reply to Antinori et al.
authors: LA BioMed and the Division of Infectious Diseases, Harbor-UCLA Medical Center, Torrance.
authors: David A
authors: DA
authors: Miller
authors: Center of Excellence for Chagas Disease, Olive View-UCLA Medical Center, Sylmar, California.
authors: Mahmoud M
authors: MM
authors: Traina
authors: Center of Excellence for Chagas Disease, Olive View-UCLA Medical Center, Sylmar, California.
authors: Sheba K
authors: SK
authors: Meymandi
mesh_terms: D014355:Chagas Disease / Q000188:drug therapy*; D064420:Drug-Related Side Effects and Adverse Reactions / Q000453:epidemiology*; D005260:Female; D006801:Humans; D008297:Male; D009593:Nitroimidazoles / Q000009:adverse effects*; D014344:Trypanocidal Agents / Q000009:adverse effects*
chemical_list: D009593:Nitroimidazoles; D014344:Trypanocidal Agents